1466 — Baijin Life Science Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Baijin Life Science Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	24.4	23.6	41.3	37.9	47.8
Net Total Accounts Receivable
Net Total Receivables	39.2	26.6	7.44	30.2	97
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	90	79.6	98.9	121	227
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.75	2.55	0.979	8.78	16.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	91.8	82.1	99.9	197	290
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.5	45.5	21.1	41	49.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	45.8	46.2	21.6	100	151
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	45.9	35.9	78.3	96.3	139
Total Liabilities & Shareholders' Equity	91.8	82.1	99.9	197	290
Total Common Shares Outstanding